Carr Patricia's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Mar 8, 2024
- Accession no.
- 0001765581-24-000038
- Filed
- Mar 8, 2024
- Trade date
- Mar 6-7, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $438.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carr PatriciaCIK 0001784606 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Ordinary Shares | SSaleDisposed | −1,236 | $120.85 | −$149,370.6 | 9,064 | Direct | |
| Mar 6, 2024 | Ordinary Shares | SSaleDisposed | −700 | $117.51 | −$82,257 | 8,364 | Direct | |
| Mar 7, 2024 | Ordinary Shares | SSaleDisposed | −1,768 | $116.98F2 | −$206,820.64 | 6,596 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $116.93 to $117.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.